These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2262243)

  • 1. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors.
    Zanetti R; Franceschi S; Rosso S; Bidoli E; Colonna S
    Int J Epidemiol; 1990 Sep; 19(3):522-6. PubMed ID: 2262243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.
    Gallagher RP; Elwood JM; Hill GB; Coldman AJ; Threlfall WJ; Spinelli JJ
    Br J Cancer; 1985 Dec; 52(6):901-7. PubMed ID: 4074642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use.
    Holly EA; Cress RD; Ahn DK
    Am J Epidemiol; 1995 May; 141(10):943-50. PubMed ID: 7741124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous malignant melanoma in women and the role of oral contraceptives.
    Gefeller O; Hassan K; Wille L
    Br J Dermatol; 1998 Jan; 138(1):122-4. PubMed ID: 9536234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.
    Naldi L; Altieri A; Imberti GL; Giordano L; Gallus S; La Vecchia C;
    Ann Epidemiol; 2005 Aug; 15(7):545-50. PubMed ID: 16029848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal and reproductive factors in melanoma risk.
    Osterlind A
    Clin Dermatol; 1992; 10(1):75-8. PubMed ID: 1504931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
    Holly EA; Weiss NS; Liff JM
    J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and skin neoplasia.
    Green A
    Contraception; 1991 Jun; 43(6):653-66. PubMed ID: 1868736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.
    Jorgensen C; Picot MC; Bologna C; Sany J
    Ann Rheum Dis; 1996 Feb; 55(2):94-8. PubMed ID: 8712873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive use and invasive cervical cancer.
    Parazzini F; la Vecchia C; Negri E; Maggi R
    Int J Epidemiol; 1990 Jun; 19(2):259-63. PubMed ID: 2376433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parity and primary liver cancer among young women.
    Hsing AW; McLaughlin JK; Hoover RN; Co Chien HT; Blot WJ; Fraumeni JF
    J Natl Cancer Inst; 1992 Jul; 84(14):1118-9. PubMed ID: 1619686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal factors and melanoma in women.
    Green A; Bain C
    Med J Aust; 1985 Apr; 142(8):446-8. PubMed ID: 3982348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy.
    Parazzini F; Hildesheim A; Ferraroni M; La Vecchia C; Brinton LA
    Int J Epidemiol; 1990 Sep; 19(3):539-45. PubMed ID: 2135870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy.
    Gallus S; Naldi L; Martin L; Martinelli M; La Vecchia C;
    Melanoma Res; 2006 Feb; 16(1):83-7. PubMed ID: 16432461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.